Clinical Study of AK1820 (Isavuconazonium Sulfate) for the Treatment of Deep Mycosis

NCT03471988 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Deep Mycosis

Interventions

DRUG: AK1820
DRUG: Voriconazole

Sponsor

Asahi Kasei Therapeutics Corporation